Abstract
Objective: The retrospective analysis of the case files of children with differentiated thyroid carcinoma (DTC) was performed to define the disease by its presentation, clinical course and outcome of radioiodine therapy.Methods: Between 1967 to October 2002,1754 patients with thyroid cancer were treated in the Dept of Neuclear Medicine, AIIMS, out of which 122 (7%) were ≶ 20 years of age (71 girls and 51 boys). The mean age was 15.8 ± 3.6 years and the mean duration of follow-up was 90 ± 59.3 months. Mean tumor size was 4.4 cm. Histologically, 85% of the patients had papillary and rest follicular carcinoma. Cervical lymph node involvement was seen in 64%, and distant metastases, mainly pulmonary, in 23% of the patients. The presentation of the disease was very aggressive in the first decade of life with male preponderance. All but one patient in this age group had nodal and/or distant metastases; in 83.3% the disease had spread to the lymph nodes and 67% had metastases to the lungs. The post-surgery 48-hour mean radioiodine neck uptake was 10.5 ± 7.6%.Results: 94% of the residual thyroid, 88% of nodal metastases and 71% of pulmonary metastases were ablated requiring mean cumulative doses of 2.8 ± 2.7 GBq, 4.5 ± 2.7 GBq and 10.4 ± 7.9 GBq of131I, respectively. Average number of doses required for remnant, nodal and pulmonary metastases ablation were 1.3, 2.2 and 3.3, respectively. 80% of the patients with only remnant thyroid tissue and 50% with cervical lymph node metastases got ablated with a single dose of131I. Overall, 87% patients were currently free of disease. While, nine patients had nodal recurrence between surgery and radioiodine treatment, no recurrence was observed thereafter and 3 disease related deaths producing overall mortality of 2.5% (all in children ≶10 years of age) were seen in the mean follow-up of 7.5 years.Conclusion: Differentiated thyroid cancer in children and adolescents is rare but aggressive. The biological behavior differs from that in adults and is related to the age. Younger the age (≶10 years), more aggressive and widespread is the disease with male preponderance and high mortality. The Post-surgical radioiodine ablation/therapy is an important and effective adjuvant in the management of DTC in children and adolescents and even though they present with advance disease, long-term survival and overall prognosis is good.
Similar content being viewed by others
References
Young J, Percy C. Surveillance, epidemiology and end results: Incidence and mortality data.NCI Monog 1981; 57:1973–1977.
Brennan MF, MaCdonald JS. Cancer of endocrine system. In De Vita VT, Hellman S, Rosenberg SA, eds.Cancer Principles and Practice of Oncology. Philadelphia: J.B. Lippincot, 1985: 1179–1192.
Buckwalter JA, Guril NJ, Thomas CG. Cancer of the thyroid in youth.World J Surg 1981; 5:15–25.
Fassina AS, Rupolo M, Pelizzo MR, Casara D. Thyroid cancer in children and adolescents.Tumori 1994; 80: 257–262.
Aune BB. Thyroid neoplasms. In Stacker JT, Dehner LP, eds.Pediatric Pathology, Lippincott; Philadelphia 1992; 976–980.
Desjardins JG, Bass J, Leboeuf G. A twenty year experience with thyroid carcinoma in children.Pediatr Surg 1988; 23: 709–713.
Merrick Y, Hansen HS. Thyroid cancer in children and adolescents in Denmark.Eur J Surg Oncol 1989; 15:49–53.
Mosso ML, Colombo R, Giordano Let al. Childhood cancer registry of the province of Torino, Italy: Survival, incidence and mortality over 20 years.Cancer 1992; 69:1300–1306.
Zimmerman D, Hay ID, Ian Ret al. Papillary thyroid carcinoma in children and adults: Long-term follow-up of 1039 patients conservatively treated at one institution during three decades.Surgery 1988; 104:1157–1166.
Rosen IB, Bowden I, Luk SC, John AS. Aggressive thyroid cancer in low risk age population.Surgery 1987; 102: 1075–1080.
Cady B, Rossi R. An expanded view of risk-group definition in differentiated thyroid carcinoma.Surgery 1988; 104:947–953.
La Quaglia MP, Black T, Holcomb G W 3rd, Sklar C, Azizkhan R G, Hasse G M. Differentiated thyroid cancer: clinical characteristics, treatment, and outcome in patients under 21 years of age who presented with distant metastases. A report from the surgical discipline committee of the children’s cancer group.J Paed Surg 2000; 35:955–960.
Bal CS, Padhy AK, Jana S, Pant GS, Basu AK. Prospective randomized clinical trial to evaluate the optimal dose of131I for remnant ablation in patients with differentiated thyroid carcinoma.Cancer 1996; 77: 2574–2580.
Heidinger LE, Sobin LH. International histological classification of tumors. Geneva: World Health Organisation 1974; 17–26.
Exelby PE, Frazell E L. Carcinoma of the thyroid in children.Surg Clin North Amer 1969; 49:249–259.
Liechty RD, Safaie-shirazi S, Soper RT. Carcinoma of the thyroid in children.Surg Gynae Obstet 1972; 134: 595–599.
Buckwalter JA, Thomas CG, Freemen JB. Is childhood thyroid cancer a lethal disease?Ann Surg 1975; 181: 632–639.
Withers EH, Rosenfeld L, O’Neil JLet al. Long-term experience with childhood thyroid carcinoma.J Pediatr Surg 1979; 14: 332–335.
Zohar Y, Strauss M, Laurian N. Adolesent verses adult thyroid carcinoma.Laryngoscope 1981; 96: 555–559.
Goepfert H, Dichtel WJ, Samaan NA. Thyroid cancer in children and teenagers.Arch Otolaryngol 1984; 110: 72–75.
Tallroth E, Backdahl A, Einhom Wet al. Thyroid carcinoma in children and adolescents.Cancer 1986; 58:2329–2332.
Schlumberger M, De Vathaire F, Travagli Pet al. Differentiated thyroid carcinoma in childhood: Long-term follow-up of 72 patients.J Clin Endocrinol Metab 1987; 65:1088–1094.
La QuagUa MP, Corbally M T, Heller Get al. Recurrence and morbidity in differentiated thyroid carcinoma in children.Surgery 1988; 104:1149–56.
Ceccarelli C, Pacini F, Lippi Fet al. Thyroid cancer in children and adolescents.Surgery 1988; 104:1143–1148.
Frankenthaler RA, Sellin RV, Cangir A, Goepfert H. Lymph node metastases from papillary-follicular thyroid carcinoma in young patients.Am J Surg 1990; 160:341–343.
Mazzaferri EL, JhiangSM. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer.Am J Med 1994; 97:418–427.
Massimino M, Gasparini M, Ballerini E, Delbo R. Primary thyroid carcinoma in children: A retrospective study of 20 patients.Med Pediat Oncol 1995; 24:13–17.
Gyorgy Balazs, Geza Lukas, Ferenc Juhasz, Ferenc Gyory, Eva Olah, Erzsebet Balogh. Special Features of Childhood and Juvenile Thyroid Carcinomas. JpnJ Sug 1996; 26:536–540.
Catherine A, Welch Dinauer R. Michael Tuttletet al. Clinical features associated with metastases and recurrence of differentiated thyroid cancer in children, adolescents and young adults.Clin Endocrinol 1997; 49:619–628.
Segal A, A Rad-Cohen, S Mechlis, E Lubin, R Feinmesser. Cancer of thyroid in children and adolescents.Clin Otolaryngol 1997; 22:525–528.
D Danese, A Gardini A, Farsetti S, Sciacchitano M, Andreoli A P. Thyroid carcinoma in children and adolescents.Eur J Pediatr 1997; 156:190–194.
AM Samuel, DH Shah. Differentiated Thyroid Cancer in Childhood and Adolescence. In D.H. Shah, A.M. Samuel, R.S. Rao, eds.Thyroid Cancer: An Indian Perspective; Mumbai: Quest Publications, 1999:535–562.
Jarzab B, Kalemba B, Handkiewiez, Junak D, Wtoch J, Roskosz J. Treatment of differentiated thyroid carcinoma in children and young adults: a multivariate analysis.Eur J Nucl Med 1999; 26:98–111.
Abelin T, Averkin JI, Egger Met al. Thyroid cancer in Belarus post-Chernobyl: Improved detection or increased incidence?Soz Prdventiv Med 1994; 39:189–197.
Furmanchuk AW, Averkin JI, Eglolff Bet al. Pathomor-phological findings in thyroid cancers of children from the Republic of Belarus: A study of 86 cases occurring between 1986 (“Post Chernobyl”) and 1991.Histopathology 1992; 21: 401–108.
Hamilton TE, Van Belle G, Lo Gerfo J P. Thyroid neoplasia in Marshall Islanders exposed to nuclear fallout.J Am Med Assoc 1987; 258:629–636.
Kingman S. Thyroid cancer rises after Chernobyl.Br Med J 1992; 305:601–602.
Socolov EL, Hashizume A, Neriishi S, Nitami R. Thyroid carcinoma in man after exposure to ionizing radiation. A summary of the findings in Hiroshima and Nagasaki.New Eng J Med 1963;268:406–410.
Bal CS, Padhy AK. and Kumar A. Clinical features of differentiated thyroid carcinoma in children and adolescents from a sub-Himalayan iodine-deficient endemic zone.Nucl Med Commun 2001; 22; 881–887.
Lamberg BA, Karkinen-Jaaskelainen M, Franssila KO. Differentiated follicle-derived thyroid carcinoma in children.Acta Pediatr Scand 1989; 78:419–425.
Samuel AM, Rajashekharrao B, Shah DH. Pulmonary metastases in children and adolescents with well-differentiated thyroid cancer.J Nucl Med 1998; 39:1531–1536.
Hayles AB, Kennedy RJ, Beahrs OH. Management of the child with thyroid cancer.J Am Med Assoc 1960; 173:21–28.
Winship T, Rosvoll RV. Thyroid carcinoma in childhood: Final report on a 20-years study.Clin Proc Children Hospital (Washington, DC) 1970; 26:327.
Dottorini ME, Vignati A, Mazzucchelli Let al. Differentiated thyroid carcinoma in children and adolescents: A 37-year-experience in 85 patients.J Nucl Med 1997; 38:669–675.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kumar, A., Bal, C.S. Differentiated thyroid cancer. Indian J Pediatr 70, 707–713 (2003). https://doi.org/10.1007/BF02724312
Issue Date:
DOI: https://doi.org/10.1007/BF02724312